ReviewCNS drugs2021

Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis.

Amit Bar-Or et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.